Optimizing Therapy Through the Prevention and/or Management

of Adverse Events in Multiple Myeloma

Goal Statement

Case #1

Question

Venous Thromboembolism

Risk Factors for VTE in Patients With Malignancy

VTE Incidence With Thalidomide or Lenalidomide Without Thromboprophylaxis

Guideline Recommendations: Prevention of VTE

Guideline Recommendations: Prevention of VTE (cont)

Case #1 (cont)

Question

Bisphosphonate-Related ONJ

BRONJ Incidence

BRONJ Risk Factors

BRONJ Definition

Prevention of BRONJ

Strategies for Preventing BRONJ

Treatment of Patients With BRONJ

Case #2

Case #2 (cont)

Question

Peripheral Neuropathy

TiPN and BiPN

Carfilzomib: PN

Management of PN

Management of PN: TiPN

Management of PN: BiPN

Question

Myelosuppression

Myelosuppression: Bortezomib

Myelosuppression: Lenalidomide

Myelosuppression: Carfilzomib

Question & Answer Session